Cagent Vascular
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease
$41MSeries D
Role not disclosedAH
Astoria Health Investors
Activity from announced rounds
Activity in this selectiontomcat-2795860b
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $41M 1 disclosed · full round size, not this investor’s share